Drupal.behaviors.print = function(context) {window.print();window.close();}>

Response Genetics Licenses BRAF Mutation Technology to GlaxoSmithKline

May 11, 2010

Response Genetics Licenses BRAF Mutation Technology to GlaxoSmithKline

Response Genetics licensed to GSK rights to use its PCR technology as part of the pact.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories